Mirati Therapeutics is only slightly up on the day, shares traded 0.47% higher on the day.
The Biotechnology company isn't at an immediate support or resistance level that might be predictive. Mirati Therapeutics hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. MRTX might find some support at the 123.02 level, buyers might push the price back up from here. But it's not very clear what will happen.
Analysts are very concerned for the future of Mirati Therapeutics and are providing negative ratings. This may coincide with future price drops. The current Analysts Sentiment Score is -106.04. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. BMO Capital Markets provided a price target decease of -15.25% to $50.00 from $59.00 on 2023-03-01. Morgan Stanley announced a lowering of their price target to $50.00 from $60.00 on 2023-01-27. B. Riley gave a boost to their price target and moved to $56.00 from $52.00 on 2023-01-23. SVB Leerink dropped their price target by -11.76% to $75.00 on 2022-12-14. On 2022-12-14 Barclays lowered their price target by -46.75% to $90.00. Needham & Company LLC announced that they are initiating coverage with a rating of Hold on 2022-12-14. Piper Sandler gave a boost to their price target and moved to $87.00 from $84.00 on 2022-12-13. On 2022-12-09 Stifel Nicolaus decreased their price target to 73.00. Citigroup downgraded from Buy to Neutral on 2022-12-09 and they lowered their price target by -56.2% to $53.00 from a previous target of $121.00. JPMorgan Chase & Co. released a downgrade on 2022-12-08 from Overweight to Neutral and dropped their 1 year price target to $65.00 which is down from $94.00.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| MRTX | -106.04 | 15.65 | -63.64 | 22.99 | -187.09 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| MRTX | 0.16 | 1.36 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| MRTX | 16.07 | %19.066 | 5.9 | 35.706 | 9880000 |
| Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | 367 | 1.85 | -0.88 | -10.56 | 1.85 | -7.04 | -22.15 | 31.57 | -13.77 | -17.27 | -13.81 | -41814.93 | -3164.24 | 0.95 | 21.19 | 6.54 | 48.84 |
| Healthcare | 617 | 2.00 | -0.17 | -8.49 | 2.07 | -6.13 | -23.93 | 31.85 | -11.33 | -14.45 | -14.07 | -36805.91 | -4054.41 | 1.05 | 22.33 | 5.93 | 36.37 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| MRTX | 1.00 |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DNLI | Denali Therapeutics Inc. | 0.95 | -0.30 | -2.35 | -20.42 | -19.99 | -19.38 | -30.23 | 15 | -14.17 | -11.37 | -5.44 | -17869.11 | -140.02 | 0 | 0 | 7.15982 |
| SAGE | Sage Therapeutics, Inc | 0.89 | -1.57 | -0.07 | 2.61 | 8.22 | 4.92 | 28.84 | 54 | 20.13 | 16.62 | 33.67 | -4282.46 | -5290.62 | 0 | 0 | 8.58313 |
| VCYT | Veracyte, Inc. | 0.81 | 3.29 | 1.44 | -2.76 | -12.20 | 28.54 | -14.62 | 38 | 7.60 | 9.72 | 15.50 | -17160.89 | -1908.81 | 0 | 0 | 4.12529 |
| KRTX | Karuna Therapeutics, Inc. | 0.8 | -11.60 | -13.76 | -15.14 | -20.30 | -33.30 | 38.99 | 30 | 14.75 | 10.26 | 5.85 | -9676.86 | -11045.08 | 0 | 100 | 5.17169 |
| CDXS | Codexis, Inc. | 0.75 | 4.66 | -2.88 | -26.55 | -13.49 | -40.32 | -79.80 | 23 | -35.76 | -64.62 | -79.91 | -76647.39 | 0.00 | 0 | 0 | 7.95482 |
| CLDX | Celldex Therapeutics, Inc | 0.74 | -6.12 | -10.61 | -6.32 | -13.82 | 30.11 | 15.10 | 39 | 18.06 | 56.23 | 52.89 | -2418.99 | -10647.94 | 0 | 0 | 8.46357 |
| SELB | Selecta Biosciences, Inc | 0.73 | -1.56 | -10.00 | -23.17 | 23.53 | -26.32 | -13.70 | 32 | 6.93 | 14.43 | 18.86 | -2854.56 | -2916.17 | 0 | 0 | 7.31536 |
| AMWL | American Well Corporation | 0.73 | 4.26 | -0.41 | -32.32 | -23.91 | -35.36 | -35.86 | 25 | -23.24 | -31.66 | -17.11 | -21057.90 | 0.00 | 0 | 150 | 6.48203 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
